売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2023/12 |
448,788 |
70.7% |
| 2022/12 |
431,892 |
68.8% |
| 2021/12 |
368,433 |
69.0% |
| 2020/12 |
271,141 |
69.4% |
| 2019/12 |
200,882 |
68.4% |
| 2018/12 |
147,094 |
|
| 2017/12 |
104,352 |
|
| 2016/12 |
76,846 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2023/12 |
-61,399 |
-13.7% |
| 2022/12 |
-84,183 |
-19.5% |
| 2021/12 |
-76,249 |
-20.7% |
| 2020/12 |
-72,214 |
-26.6% |
| 2019/12 |
-47,228 |
-23.5% |
| 2018/12 |
-42,091 |
|
| 2017/12 |
-19,285 |
|
| 2016/12 |
-10,826 |
|
|
（単位：%）
|
2016/12
|
2017/12
|
2018/12
|
2019/12
|
2020/12
|
2021/12
|
2022/12
|
2023/12
|
|
売上高
|
76,846
|
104,352
|
147,094
|
200,882
|
271,141
|
368,433
|
431,892
|
448,788
|
|
売上成長率（％）
|
-
|
|
|
36.6
|
35.0
|
35.9
|
17.2
|
3.9
|
|
売上原価
|
23,767
|
31,503
|
46,810
|
63,535
|
83,028
|
114,216
|
134,934
|
131,487
|
|
売上総利益
|
53,079
|
72,849
|
100,284
|
137,347
|
188,113
|
254,217
|
296,958
|
317,301
|
|
売上総利益率（％）
|
|
|
|
68.4
|
69.4
|
69.0
|
68.8
|
70.7
|
|
研究開発費
|
14,765
|
22,241
|
41,305
|
50,024
|
62,512
|
81,647
|
95,986
|
95,468
|
|
営業費用
|
63,905
|
92,134
|
142,375
|
184,575
|
260,327
|
330,466
|
381,141
|
378,700
|
|
営業利益
|
-10,826
|
-19,285
|
-42,091
|
-47,228
|
-72,214
|
-76,249
|
-84,183
|
-61,399
|
|
営業利益率 (%)
|
|
|
|
-23.5
|
-26.6
|
-20.7
|
-19.5
|
-13.7
|
|
経常（税引前）利益
|
-11,310
|
-19,587
|
-46,719
|
-51,825
|
-95,663
|
-107,375
|
-63,572
|
-43,597
|
|
経常（税引前）利益率（％）
|
-14.7
|
-18.8
|
-31.8
|
-25.8
|
-35.3
|
-29.1
|
-14.7
|
-9.7
|
|
法人税等合計
|
-24
|
47
|
796
|
425
|
-2,267
|
-12,579
|
-2,398
|
3,708
|
|
実効税率（％）
|
|
|
|
-0.8
|
2.4
|
11.7
|
3.8
|
-8.5
|
|
純利益
|
-11,286
|
-19,634
|
-47,515
|
-52,250
|
-93,396
|
-94,796
|
-61,174
|
-47,305
|
|
純利益率（％）
|
|
|
|
-26.0
|
-34.4
|
-25.7
|
-14.2
|
-10.5
|
|
一株あたり利益
|
-0.68
|
-0.7
|
-1.63
|
-1.58
|
-2.7
|
-2.5
|
-1.54
|
-1.16
|
|
希薄化後一株あたり利益
|
-0.68
|
-0.7
|
-1.63
|
-1.58
|
-2.7
|
-2.5
|
-1.76
|
-1.31
|
|
EBITDA
|
|
|
|
-27,557
|
-41,455
|
-23,081
|
-23,583
|
-2,584
|
|
EBITDAマージン（％）
|
|
|
|
-13.7
|
-15.3
|
-6.3
|
-5.5
|
-0.6
|